Eli Magen

2.5k total citations
91 papers, 1.4k citations indexed

About

Eli Magen is a scholar working on Rheumatology, Physiology and Immunology. According to data from OpenAlex, Eli Magen has authored 91 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Rheumatology, 23 papers in Physiology and 23 papers in Immunology. Recurrent topics in Eli Magen's work include Urticaria and Related Conditions (25 papers), Asthma and respiratory diseases (14 papers) and Dermatology and Skin Diseases (13 papers). Eli Magen is often cited by papers focused on Urticaria and Related Conditions (25 papers), Asthma and respiratory diseases (14 papers) and Dermatology and Skin Diseases (13 papers). Eli Magen collaborates with scholars based in Israel, Russia and United States. Eli Magen's co-authors include Eugene Merzon, Ilan Green, Shlomo Vinker, Avivit Golan‐Cohen, Joseph Mishal, Ariel Israel, Menachem Schlesinger, Eytan Ruppin, Alejandro A. Schäffer and Kuznik Bi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and BMJ.

In The Last Decade

Eli Magen

81 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eli Magen Israel 22 360 337 282 168 168 91 1.4k
Alex Richter United Kingdom 25 650 1.8× 367 1.1× 118 0.4× 80 0.5× 158 0.9× 103 2.2k
Jeong‐Hee Choi South Korea 21 138 0.4× 261 0.8× 310 1.1× 108 0.6× 274 1.6× 91 1.2k
P Roux‐Lombard Switzerland 20 397 1.1× 779 2.3× 383 1.4× 119 0.7× 147 0.9× 37 2.3k
Michael J. Brown United Kingdom 16 258 0.7× 536 1.6× 167 0.6× 64 0.4× 127 0.8× 30 1.6k
Tomoyuki Kakugawa Japan 23 91 0.3× 164 0.5× 330 1.2× 163 1.0× 321 1.9× 95 1.9k
Danilo Villalta Italy 28 166 0.5× 278 0.8× 284 1.0× 369 2.2× 80 0.5× 81 2.7k
Tilmann Kallinich Germany 27 130 0.4× 1.3k 3.8× 359 1.3× 113 0.7× 360 2.1× 116 2.6k
Der-Yuan Chen Taiwan 20 77 0.2× 312 0.9× 449 1.6× 88 0.5× 74 0.4× 46 1.3k
Bruno Laganà Italy 21 272 0.8× 255 0.8× 450 1.6× 80 0.5× 136 0.8× 65 1.5k
R. Jaussaud France 22 233 0.6× 478 1.4× 176 0.6× 226 1.3× 397 2.4× 93 1.7k

Countries citing papers authored by Eli Magen

Since Specialization
Citations

This map shows the geographic impact of Eli Magen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eli Magen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli Magen more than expected).

Fields of papers citing papers by Eli Magen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eli Magen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eli Magen. The network helps show where Eli Magen may publish in the future.

Co-authorship network of co-authors of Eli Magen

This figure shows the co-authorship network connecting the top 25 collaborators of Eli Magen. A scholar is included among the top collaborators of Eli Magen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eli Magen. Eli Magen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Israel, Ariel, Sarah Israel, Abraham Weizman, et al.. (2025). Atovaquone-proguanil and reduced digestive cancer risk: a Toxoplasma gondii connection. Gut Microbes. 17(1). 2545412–2545412. 1 indexed citations
2.
Chikovani, Tinatin & Eli Magen. (2025). In Situ Vaccination by Tumor Ablation: Principles and Prospects for Systemic Antitumor Immunity. Vaccines. 13(11). 1114–1114.
3.
Magen, Eli, et al.. (2024). Increased Rates of Infectious Diseases in Fibromyalgia Patients: A Population-Based Case-Control Study. Biomedicines. 12(12). 2821–2821. 1 indexed citations
4.
Magen, Eli, et al.. (2024). Chronic idiopathic eosinopenia, allergic, and autoimmune disorders. The Journal of Allergy and Clinical Immunology In Practice. 12(7). 1933–1936.e1.
5.
Merzon, Eugene, Shai Ashkenazi, Eli Magen, et al.. (2024). Increased Prevalence of Attention Deficit Hyperactivity Disorder in Individuals with Selective Immunoglobulin A Deficiency: A Nationwide Case–Control Study. Journal of Clinical Medicine. 13(20). 6075–6075.
6.
Merzon, Eugene, Eli Magen, Shai Ashkenazi, et al.. (2023). The Association between Glucose 6-Phosphate Dehydrogenase Deficiency and Attention Deficit/Hyperactivity Disorder. Nutrients. 15(23). 4948–4948. 1 indexed citations
7.
Magen, Eli, Eugene Merzon, Ilan Green, et al.. (2023). Chronic idiopathic eosinopenia and chronic spontaneous urticaria. The Journal of Allergy and Clinical Immunology In Practice. 11(8). 2583–2586. 2 indexed citations
8.
Magen, Eli, Eugene Merzon, Ilan Green, et al.. (2023). Selective IgA deficiency and COVID-19. The Journal of Allergy and Clinical Immunology In Practice. 11(6). 1936–1938. 3 indexed citations
9.
Magen, Eli, et al.. (2022). Case of benralizumab‐induced exacerbations of chronic spontaneous urticaria. SHILAP Revista de lepidopterología. 10(6). e05930–e05930. 6 indexed citations
10.
Magen, Eli, Sumit Mukherjee, Eugene Merzon, et al.. (2022). Clinical and Molecular Characterization of a Rare Case of BNT162b2 mRNA COVID-19 Vaccine-Associated Myositis. Vaccines. 10(7). 1135–1135. 15 indexed citations
11.
Israel, Ariel, Eugene Merzon, Yotam Shenhar, et al.. (2022). Clinical and Laboratory Features in the Israeli Population with COVID-19 Infection after Pfizer-BioNTech mRNA Booster Vaccination. Vaccines. 10(5). 636–636. 1 indexed citations
12.
Israel, Ariel, Alejandro A. Schäffer, Eugene Merzon, et al.. (2022). A Calculator for COVID-19 Severity Prediction Based on Patient Risk Factors and Number of Vaccines Received. Microorganisms. 10(6). 1238–1238. 2 indexed citations
13.
Merzon, Eugene, Ilan Green, Shlomo Vinker, et al.. (2021). The use of aspirin for primary prevention of cardiovascular disease is associated with a lower likelihood of COVID‐19 infection. FEBS Journal. 288(17). 5179–5189. 33 indexed citations
14.
Green, Ilan, Avivit Golan‐Cohen, Shlomo Vinker, et al.. (2021). Higher rates of allergies, autoimmune diseases and low-grade inflammation markers in treatment-resistant major depression. Brain Behavior & Immunity - Health. 16. 100313–100313. 15 indexed citations
15.
Israel, Ariel, Eugene Merzon, Alejandro A. Schäffer, et al.. (2021). Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection: test negative design study. BMJ. 375. e067873–e067873. 103 indexed citations
16.
Israel, Ariel, Yotam Shenhar, Ilan Green, et al.. (2021). Large-Scale Study of Antibody Titer Decay following BNT162b2 mRNA Vaccine or SARS-CoV-2 Infection. Vaccines. 10(1). 64–64. 141 indexed citations
17.
Bi, Kuznik, et al.. (2020). Effect of tocilizumab and thymalin on systemic inflammation in patients with COVID-19. Vrach. 31(11). 87–96. 2 indexed citations
18.
Magen, Eli & Tinatin Chikovani. (2020). Recurrent spontaneous clearance of psoriasis during exacerbations of concomitant chronic spontaneous urticaria. SHILAP Revista de lepidopterología. 8(8). 1544–1546. 3 indexed citations
19.
Lukyanov, S. А., et al.. (2020). The use of Thymaline to correct immune status deviations in COVID-19 (rationale for the use of drug and clinical case). Vrach. 31(8). 74–82. 5 indexed citations
20.
Shalom, Guy, Khalaf Kridin, Eli Magen, et al.. (2018). Chronic urticaria and osteoporosis: a longitudinal, community‐based cohort study of 11 944 patients. British Journal of Dermatology. 180(5). 1077–1082. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alex Richter Breakdown of academic impact, for papers by Jeong‐Hee Choi Breakdown of academic impact, for papers by P Roux‐Lombard Breakdown of academic impact, for papers by Michael J. Brown Breakdown of academic impact, for papers by Tomoyuki Kakugawa Breakdown of academic impact, for papers by Danilo Villalta Breakdown of academic impact, for papers by Tilmann Kallinich Breakdown of academic impact, for papers by Der-Yuan Chen Breakdown of academic impact, for papers by Bruno Laganà Breakdown of academic impact, for papers by R. Jaussaud
Rankless by CCL
2026